Patent · US Active

Laser-assisted intradermal administration of active substances

US10828354B2 · kind B2 · utility

0Cited by

1References

13Claims

0Family size

Assignee

PANTEC BIOSOLUTIONS AG · LI

Inventors

Reinhard Braun · Lustenau, AT
Dorothea Terhorst · Marseilles, FR
Sandrine Henri · Marseilles, FR
Bernard Malissen · Marseilles, FR
Yoan J. Machado · Salzburg, AT
Mellissa Mayr · Salzburg, AT
Theresa Thalhamer · Salzburg, AT
Veronika Höpflinger · Salzburg, AT
Josef Thalhamer · Salzburg, AT
Richard Weiss · Salzburg, AT

Key dates

Filing date	Apr 20, 2016
Grant date	Nov 10, 2020
Priority date	—
Expiry date	Apr 20, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/33
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A vaccine preparation comprising an antigen for use in the prophylactic or therapeutic treatment of a subject by intradermal administration through laser-generated micropores, wherein the antigen is linked to a binder of a dermal migratory antigen-presenting cell (APC); and a pharmaceutical preparation comprising an active substance for use in the prophylactic or therapeutic treatment of a subject by intradermal administration through laser-generated micropores, for regional delivery to a target location. The invention further relates to the laser-assisted intradermal administration of antigens accompanied by repeated chemotherapy.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.